EV3

Vensana Capital Strengthens Team with Promotions and Addition of Venture Partner

Retrieved on: 
Thursday, January 4, 2024

Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.

Key Points: 
  • Vensana Capital , a leading medical technology-focused venture capital and growth equity investment firm, today announced the promotions of Amrinder Singh, Cynthia Yee, Greg Banker, and Mike Kramer to Partner and Steve Schwen to Partner & Chief Financial Officer.
  • The firm also announced the addition of veteran medtech leader Bill Hoffman as a Venture Partner.
  • “Since launching Vensana in 2019, we have set out to build the deepest, most experienced team in our sector.
  • Bill Hoffman joins Vensana Capital as a Venture Partner.

Kia to Announce Future PBV Vision and Model Lineup at CES 2024

Retrieved on: 
Wednesday, December 13, 2023

The brand is set to introduce its future PBV product lineup and business vision, along with physically showcasing several PBV concept models.

Key Points: 
  • The brand is set to introduce its future PBV product lineup and business vision, along with physically showcasing several PBV concept models.
  • Kia PBV is a 'Total Mobility Solution' combining fit-for-purpose EVs with advanced software solutions that will open the door to new businesses and lifestyles.
  • Kia will also operate an indoor PBV exhibition in the LVCC West Hall and an outdoor EV exhibition in the LVCC Central Plaza between January 9 - 12.
  • Kia's CES 2024 press conference will be held at Mandalay Bay at 3pm (PST) on Monday, January 8 and will be livestreamed on worldwide.kia.com.

Kia to Announce Future PBV Vision and Model Lineup at CES 2024

Retrieved on: 
Wednesday, December 13, 2023

The brand is set to introduce its future PBV product lineup and business vision, along with physically showcasing several PBV concept models.

Key Points: 
  • The brand is set to introduce its future PBV product lineup and business vision, along with physically showcasing several PBV concept models.
  • Kia PBV is a 'Total Mobility Solution' combining fit-for-purpose EVs with advanced software solutions that will open the door to new businesses and lifestyles.
  • Kia will also operate an indoor PBV exhibition in the LVCC West Hall and an outdoor EV exhibition in the LVCC Central Plaza between January 9 - 12.
  • Kia's CES 2024 press conference will be held at Mandalay Bay at 3pm (PST) on Monday, January 8 and will be livestreamed on worldwide.kia.com.

Bill Hoffman Joins Magenta Medical's Board of Directors

Retrieved on: 
Tuesday, November 21, 2023

KADIMA, Israel, Nov. 21, 2023 /PRNewswire/ -- William (Bill) Hoffman has joined Magenta Medical's Board of Directors as an independent industry expert.

Key Points: 
  • KADIMA, Israel, Nov. 21, 2023 /PRNewswire/ -- William (Bill) Hoffman has joined Magenta Medical's Board of Directors as an independent industry expert.
  • Magenta Medical is developing the Elevate™ System, the smallest heart pump in the world.
  • Mr. Hoffman currently serves as a member of the board of directors of Inari Medical, where he was CEO from 2015 until 2022.
  • "Bill Hoffman is a widely respected and accomplished leader in the MedTech industry.

ACCELERATING THE ART OF ELECTRIC MOBILITY: KIA INTRODUCES ALL-ELECTRIC EV3, EV4 CONCEPT MODELS AT THE 2023 LOS ANGELES AUTO SHOW

Retrieved on: 
Thursday, November 16, 2023

LOS ANGELES, Nov. 16, 2023 /PRNewswire/ -- Today, Kia America introduced the all-electric EV3 and EV4 concept models at the 2023 Los Angeles Auto Show. Showcasing Kia's cutting-edge electric platform technology, styling derived from the tenets of the Opposites United design philosophy, and a commitment to a leading color, material, and finish (CMF) strategy, the Concept EV3 and Concept EV4 represent contrasting vehicle typologies with a common thread. Like other Kia design studies, the Concept EV3 and Concept EV4 offer visions of potential future products.

Key Points: 
  • Like other Kia design studies, the Concept EV3 and Concept EV4 offer visions of potential future products.
  • "That's why we came to Los Angeles and America's savviest EV consumers, to gauge reaction to two potential opportunities within the Kia lineup."
  • Earlier this year, at the launch of the EV9 flagship electric SUV in March, Kia introduced 10 must-have items that it would like to use in new Kia models – including the Concept EV3 and Concept EV4.
  • The Concept EV3 features a high degree of inspiration from the "Joy for Reason" pillar of the Opposites United design philosophy.

Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading

Retrieved on: 
Thursday, July 13, 2023

SECAUCUS, N.J. and MELBOURNE, Australia, July 13, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, today announced the launch of a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with  Envision Sciences. Envision Sciences Pty Ltd. is an Australian-based clinical diagnostics company developing a pipeline of biomarker-based cancer diagnostic and prognostic tests in tissue and blood.

Key Points: 
  • The new, tissue-based test service is intended to address the pressing clinical need for tests to help identify and differentiate potentially aggressive cases of prostate cancer in men.
  • Although it is one of the most common cancers globally, existing prostate cancer testing methods, particularly for early, lower grade stages, have limited accuracy across pathologists.3
    "Our goal for this innovative prostate biomarker test is to improve the accuracy of grading prostate cancer biopsies.
  • "Our patented technology provides a novel approach to visualizing prostate cancer tissue and improving accuracy in grading the cancer by pathologists.
  • We expect the test to enhance current prostate cancer histology practice and improve the information available to clinicians, enabling them to better align cancer grades with treatment options."

Imperative Care Appoints Ariel Sutton to General Manager of Stroke Business

Retrieved on: 
Monday, April 3, 2023

Imperative Care , a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of Ariel Sutton to the newly-created position of General Manager of the company’s Stroke business.

Key Points: 
  • Imperative Care , a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced the appointment of Ariel Sutton to the newly-created position of General Manager of the company’s Stroke business.
  • View the full release here: https://www.businesswire.com/news/home/20230403005223/en/
    Imperative Care Appoints Ariel Sutton to General Manager of Stroke Business (Photo: Business Wire)
    “I am honored to take on this new role as Imperative Care continues to drive a patient-first approach to stroke treatment,” said Ariel.
  • Prior to joining Imperative Care, Ariel had key marketing and product management roles at Cardinal Health, Access Closure, ev3, FoxHollow Technologies, and Johnson & Johnson’s LifeScan division.
  • “Under Ariel’s leadership, Imperative Care has remained focused on elevating care and bringing life-saving technologies to patients affected by stroke,” said Daniel Davis, Imperative Care’s President and Chief Operating Officer.

Andrena Raises $15 Million in Series A Funding, Advancing Its Mission to Provide Next-Gen & Affordable Internet for All

Retrieved on: 
Monday, February 27, 2023

Andrena uses cutting-edge radio technology to create wireless networks by deploying a series of antennas to provide Internet across urban geographies.

Key Points: 
  • Andrena uses cutting-edge radio technology to create wireless networks by deploying a series of antennas to provide Internet across urban geographies.
  • The company partners with real estate owners and property managers to provide affordable Internet to their residents, while simultaneously future-proofing properties with a connectivity fabric for smart-home technology.
  • "In the process of building a new affordable Internet solution, we created a system that simultaneously caters to luxury apartments as well.
  • Last year, through a contract with the Jersey City Housing Authority, Andrena partnered with the city to provide public housing residents with a new affordable Internet option.

Meet Jim Corbett - Chief Executive Officer, AVITA Medical, Inc.

Retrieved on: 
Friday, November 18, 2022

Valencia, California--(Newsfile Corp. - November 17, 2022) - On September 28, 2022, AVITA Medical, Inc. appointed Jim Corbett as Chief Executive Officer, effective immediately.

Key Points: 
  • Valencia, California--(Newsfile Corp. - November 17, 2022) - On September 28, 2022, AVITA Medical, Inc. appointed Jim Corbett as Chief Executive Officer, effective immediately.
  • Throughout Jim's career, he has served as CEO of 3 publicly traded companies: MTIX (Microtherapeutics), ev3, and Alphatec Spine.
  • AVITA Medical is a regenerative medicine company leading the development and commercialization of devices and autologous cellular therapies for skin restoration.
  • AVITA Medical's first U.S. product, the RECELL System, was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

Doug Kohrs appointed to Sequana Medical Board of Directors

Retrieved on: 
Tuesday, July 19, 2022

Mr. Kohrs is a highly experienced US executive with a track record of more than 40 years in the medical device industry.

Key Points: 
  • Mr. Kohrs is a highly experienced US executive with a track record of more than 40 years in the medical device industry.
  • Doug Kohrs brings tremendous experience to our Board from his many roles as a founder and executive of leading medical technology companies, said Pierre Chauvineau, Chairman of the Board at Sequana Medical.
  • Mr. Kohrs added: I look forward to working with the Sequana Medical Board and management team to successfully bring the alfapump and DSR treatments to patients in need.
  • Mr. Kohrs currently serves on the Board of Directors of Cerapedics, Lima Orthopedics, Osteal Therapeutics, UroTronic, and Vergent Bioscience.